Greater examination aided in accurate staging and improved survival in pure-solid, non-small cell lung cancer.
Bone modifying agents had no effect on survival outcomes.
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.
Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.
Guidance for early identification and effective management strategies for adverse effects related to tepotinib therapy in patients with METex14 skipping NSCLC are presented in a poster at ONS Congress 2021.